Cohance Lifesciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 5, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	129,862	293,004	172,366	120,256	157,436	126,468
Market Cap Growth	-52.46%	69.99%	43.33%	-23.61%	24.49%	394.20%
Enterprise Value	131,734	287,341	165,176	117,048	156,449	127,128
Last Close Price	339.45	1151.00	677.10	472.40	608.53	484.99
PE Ratio	49.34	109.38	57.40	29.24	34.69	34.90
Forward PE	28.41	80.68	44.40	26.23	30.48	29.75
PS Ratio	10.73	24.47	16.40	8.97	11.93	12.53
PB Ratio	3.31	15.92	8.40	6.93	10.31	10.71
P/TBV Ratio	5.33	29.97	8.67	7.19	10.32	10.73
P/FCF Ratio	95.07	221.22	51.78	70.21	61.79	46.55
P/OCF Ratio	62.52	101.68	44.80	26.30	47.71	33.06
EV/Sales Ratio	10.88	23.99	15.71	8.73	11.85	12.59
EV/EBITDA Ratio	42.49	70.85	40.39	20.44	27.00	28.85
EV/EBIT Ratio	62.59	87.58	46.61	22.25	28.89	31.02
EV/FCF Ratio	96.44	216.94	49.62	68.34	61.40	46.79
Debt / Equity Ratio	0.12	0.15	0.03	0.04	0.06	0.12
Debt / EBITDA Ratio	1.45	0.69	0.16	0.12	0.17	0.32
Debt / FCF Ratio	3.30	2.11	0.20	0.41	0.38	0.53
Asset Turnover	0.30	0.45	0.50	0.71	0.80	0.76
Inventory Turnover	0.84	1.85	1.32	1.87	2.24	2.19
Quick Ratio	1.59	1.78	8.61	4.17	3.85	1.56
Current Ratio	2.92	2.43	10.68	6.37	5.36	2.57
Return on Equity (ROE)	5.51%	13.61%	15.86%	25.21%	33.52%	35.78%
Return on Assets (ROA)	3.26%	7.76%	10.50%	17.33%	20.49%	19.35%
Return on Invested Capital (ROIC)	5.57%	16.10%	20.05%	31.95%	32.95%	29.89%
Return on Capital Employed (ROCE)	4.30%	12.30%	16.60%	29.10%	33.40%	32.70%
Earnings Yield	1.36%	0.91%	1.74%	3.42%	2.88%	2.86%
FCF Yield	1.05%	0.45%	1.93%	1.42%	1.62%	2.15%
Dividend Yield	-	-	-	0.64%	0.33%	0.41%
Payout Ratio	-	-	-	49.52%	22.44%	7.03%
Buyback Yield / Dilution	-0.56%	-0.49%	-	0.00%	0.00%	0.00%
Total Shareholder Return	-0.56%	-0.49%	-	0.64%	0.33%	0.41%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.